摘要
观察了比特诺尔对动物溃疡性结肠炎、消化性溃疡和胃炎的作用。结果表明:比特诺尔对溃疡性结肠炎作用显著,柳氮磺胺吡啶(SASP)与对照组相比,差异非常显著(P<0.01),得乐组与对照组相比无显著差异(P>0.05),其溃疡总数抑制率分别为47.2%、49.2%、3.8%;比特诺尔和得乐抗胃炎、胃溃疡和十二指肠溃疡作用无显著差异(P>0.05),但二者和对照组相比均有显著和非常显著的差异(P<0.05或 P<0.01)。
The pharmacodynamic of Bitnal in treatment of chronic ulcerative colitis, peptic ulcer,and gastritis was studied on animals.Results showed that Bitnal has a signifi- cant effect in treatment of ulcerative colitis in comparision with control and that its efficacy is as effective as those of SASP with a total ulcer depression rate of 47.2% for Bitnal,49.2% for SASP and 3.8% for control.There are no significant difference in efficacy between Bit- nal and Denol in treatment of above mentioned symptoms.
出处
《中国新药杂志》
CAS
CSCD
1996年第1期45-47,共3页
Chinese Journal of New Drugs
关键词
比特诺尔
溃疡性结肠炎
胃炎
胃溃疡
药理
Bitnal
Ulcerative Colitis
Gastritis
Gastric ulcer
Duodenal ulcer
